HCTI — Submission Deadline to Nasdaq Hearings Panel
May 30, 2025, 7:00:00 AM UTC
Summary
Healthcare Triangle, Inc. is due to submit its views to the Nasdaq Hearings Panel by May 30, 2025, in response to a notification regarding potential delisting from the Nasdaq Stock Market. The notification, received on May 20, 2025, cited concerns over shareholder dilution from its recent issuance of Series A and Series B Warrants. The Panel will review the company's compliance plan and determine its continued listing status, with implications for the company's trading viability also including potential shifts to the OTCQB market if necessary.
Company
HEALTHCARE TRIANGLE INC (HCTI)NASDAQ — Healthcare: Services, Health Information Services: Services-Computer Integrated Systems Design
www.healthcaretriangle.comSimilar Events
Request Hearing Before Nasdaq Panel
Australian Oilseeds Holdings Limited plans to request a hearing before the Nasdaq Hearings Panel on June 11, 2025, after being notified by Nasdaq of non-compliance with the minimum stockholders’ equity requirement of $10 million. This appeal is aimed at preventing the delisting of its securities from the Nasdaq Global Market. The company was previously granted an extension until May 30, 2025, to regain compliance, but an additional review led to the current appeal to stay the suspension of trading. Concurrently, the company has applied to list its securities on The Nasdaq Capital Market.
Appeal HearingPlan Submission Deadline for Nasdaq Compliance
Movano Inc. faces a July 21, 2025 deadline to submit a compliance plan to Nasdaq after receiving a notice for failing to file its Form 10-Q by the due date of May 15, 2025. The notice states that if Movano's plan is accepted, the company may be granted an extension until November 11, 2025, to file the overdue report. A failure to comply could lead to delisting, though Movano would have the right to appeal any adverse decision by Nasdaq.
DeadlinePlan Submission Deadline for Nasdaq Compliance
HeartCore Enterprises, Inc. must submit a plan to regain compliance with Nasdaq's minimum stockholders' equity requirement by July 8, 2025. The company received a notice from Nasdaq indicating it does not meet the $2.5 million requirement, nor does it qualify under market value of securities or net income alternatives. If the submission is accepted, Nasdaq may grant up to 180 days to meet the compliance criteria. The notification does not currently affect trading of HeartCore's shares on the Nasdaq Capital Market.
Regulatory EventSubmission Deadline for Compliance Plan to Nasdaq
Eyenovia, Inc. has a deadline of June 13, 2025, to submit a compliance plan to regain adherence to Nasdaq's Minimum Equity Requirement of $2.5 million in stockholders' equity. This directive follows a notice received by the company on April 29, 2025, indicating that its reported equity fell below the threshold necessary for continued listing on the Nasdaq Capital Market. While the notice does not immediately affect trading under the ticker "EYEN," failing to regain compliance could lead to potential delisting. The company may appeal any adverse decision regarding its compliance plan to a Hearings Panel.
Compliance Deadline